These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 15501405)
1. Implication of prostaglandin E(2) in TNF-alpha-induced release of m-calpain from HCS-2/8 chondrocytes. Inhibition of m-calpain release by NSAIDs. Fushimi K; Nakashima S; Banno Y; Akaike A; Takigawa M; Shimizu K Osteoarthritis Cartilage; 2004 Nov; 12(11):895-903. PubMed ID: 15501405 [TBL] [Abstract][Full Text] [Related]
2. Human granulosa-lutein cells express functional EP1 and EP2 prostaglandin receptors. Harris TE; Squires PE; Michael AE; Bernal AL; Abayasekara DR Biochem Biophys Res Commun; 2001 Aug; 285(5):1089-94. PubMed ID: 11478765 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation. Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853 [TBL] [Abstract][Full Text] [Related]
4. PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11beta-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa lutein cells. Chandras C; Harris TE; Bernal AL; Abayasekara DR; Michael AE J Endocrinol; 2007 Sep; 194(3):595-602. PubMed ID: 17761898 [TBL] [Abstract][Full Text] [Related]
5. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes. Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219 [TBL] [Abstract][Full Text] [Related]
6. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. Tsujisawa T; Inoue H; Nishihara T J Bone Miner Res; 2005 Jan; 20(1):15-22. PubMed ID: 15619665 [TBL] [Abstract][Full Text] [Related]
7. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Zeng L; An S; Goetzl EJ Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK; Barnes PJ; Giembycz MA Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541 [TBL] [Abstract][Full Text] [Related]
9. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. Walch L; de Montpreville V; Brink C; Norel X Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243 [TBL] [Abstract][Full Text] [Related]
10. Effects of nimesulide and sodium diclofenac on interleukin-6, interleukin-8, proteoglycans and prostaglandin E2 production by human articular chondrocytes in vitro. Henrotin YE; Labasse AH; Simonis PE; Zheng SX; Deby GP; Famaey JP; Crielaard JM; Reginster JY Clin Exp Rheumatol; 1999; 17(2):151-60. PubMed ID: 10342040 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 may induce hyperthermia through EP1 receptor in the anterior wall of the third ventricle and neighboring preoptic regions. Oka K; Oka T; Hori T Brain Res; 1997 Aug; 767(1):92-9. PubMed ID: 9365020 [TBL] [Abstract][Full Text] [Related]
12. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF. Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Hinz B; Brune K; Pahl A Biochem Biophys Res Commun; 2000 Nov; 278(3):790-6. PubMed ID: 11095985 [TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood. Page TH; Turner JJ; Brown AC; Timms EM; Inglis JJ; Brennan FM; Foxwell BM; Ray KP; Feldmann M J Immunol; 2010 Sep; 185(6):3694-701. PubMed ID: 20713883 [TBL] [Abstract][Full Text] [Related]
15. FK506 enhances triptolide-induced down-regulation of cyclooxygenase-2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients. Yao H; Zhou J; Li D; Wu N; Bader A; Höxtermann S; Altmeyer P; Brockmeyer NH Eur J Med Res; 2005 Mar; 10(3):110-6. PubMed ID: 15851377 [TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E(2) suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. Kanda N; Mitsui H; Watanabe S J Allergy Clin Immunol; 2004 Dec; 114(6):1403-9. PubMed ID: 15577845 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Heinecke LF; Grzanna MW; Au AY; Mochal CA; Rashmir-Raven A; Frondoza CG Osteoarthritis Cartilage; 2010 Feb; 18(2):220-7. PubMed ID: 19748608 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. Raveendran NN; Silver K; Freeman LC; Narvaez D; Weng K; Ganta S; Lillich JD J Pharmacol Exp Ther; 2008 May; 325(2):389-99. PubMed ID: 18281595 [TBL] [Abstract][Full Text] [Related]
20. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves. Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]